{"api":"v1","generated_at":"2026-10-01T10:19:48.247Z","licence":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/","attribution":"TOLL, with a link to the page cited"},"page":"https://tollindex.com/e/api-magentlab-com-api-calc-impede-vte-9e8c60","pinned_page":"https://tollindex.com/e/api-magentlab-com-api-calc-impede-vte-9e8c60/at/2026-10-01T05-50Z","pinned":false,"method":"https://tollindex.com/ledger/method","snapshot_at":"2026-10-01T05:50:06.230Z","snapshot_stamp":"2026-10-01T05-50Z","endpoint":{"slug":"api-magentlab-com-api-calc-impede-vte-9e8c60","canonical_url":"https://api.magentlab.com/api/calc/impede_vte","resource":"https://api.magentlab.com/api/calc/impede_vte","http_method":"POST","type":"http","x402_version":2,"registries":["cdp"],"primary_registry":"cdp","curated_by_coinbase":false,"description":"Sanfilippo 2019 IMPEDE VTE for multiple myeloma: IMiD 4, BMI>=25 1, pelvic/hip/femur fracture 4, ESA 1, doxorubicin 3, dexamethasone none/low/high 0/2/4 (high if monthly >160 mg), Asian/Pacific Islander -3 (caller-assigned), VTE history 5, tunneled line 2, thromboprophylaxis none/prophylactic/therapeutic 0/-3/-4. Unclamped. <=3 low 3.3%, 4-7 intermediate 8.3%, >=8 high 15.2%. Not a prophylaxis order. Not SAVED or Khorana.","service_name":"magent","declared_category":null,"declared_tags":["impede-vte","vte","myeloma","thrombosis","score"],"route_template":null,"registry_updated":"2026-09-28T14:27:52.515Z"},"derived":{"note":"fields no registry supplies; TOLL derives them and marks them derived on the page","title":"calc impede vte","category":"other","first_observed_by_toll":"2026-09-28T13:51:25.436Z","last_observed_by_toll":"2026-10-01T05:50:06.230Z","observation_began":"2026-09-10"},"presence":{"listed_now":true,"first_absent_at":null,"delisting_confirmed_at":null,"events":[{"registry":"cdp","at":"2026-09-28T13:51:25.437Z","event":"listed"}]},"accepts":[{"registry":"cdp","ordinal":0,"network":"eip155:8453","asset":"0x833589fcd6edb6e08f4c7c32d4f71b54bda02913","asset_name":"USD Coin","symbol":"USDC","decimals":6,"amount_display":"0.005 USDC","amount_units":0.005,"decimals_known":true,"pay_to":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"counters":{"observed_at":"2026-10-01T05:50:06.230Z","calls_30d":2,"unique_payers_30d":1,"last_called_at":"2026-09-28T14:27:52.396Z"},"validation":{"latest":{"observed_at":"2026-10-01T08:42:42.392Z","state":"pass","failed_checks":[],"endpoint_http_status":402,"run_id":"daily-2026-10-01"},"uptime":[{"days":7,"observed":5,"passed":5,"ratio":1},{"days":30,"observed":5,"passed":5,"ratio":1},{"days":90,"observed":5,"passed":5,"ratio":1}],"history_90d":[{"observed_at":"2026-10-01T08:42:42.392Z","state":"pass","failed_checks":[],"run_id":"daily-2026-10-01","state_changed":false},{"observed_at":"2026-09-30T08:06:40.182Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-30","state_changed":false},{"observed_at":"2026-09-29T20:17:20.779Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-29","state_changed":false},{"observed_at":"2026-09-28T17:23:21.745Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-28","state_changed":false},{"observed_at":"2026-09-28T16:46:04.152Z","state":"pass","failed_checks":[],"run_id":"new-after-daily-2026-09-28","state_changed":true}]},"seller":{"wallet":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","page":"https://tollindex.com/seller/0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","endpoints":844,"hosts":1},"reports":0,"registry_record":{"cdp":[{"tags":["impede-vte","vte","myeloma","thrombosis","score"],"type":"http","accepts":[{"asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/impede_vte","assetTransferMethod":"eip3009"},"payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","amount":"5000","scheme":"exact","network":"eip155:8453","maxTimeoutSeconds":600}],"quality":{"lastCalledAt":"2026-09-28T14:27:52.396Z","l30DaysTotalCalls":2,"l30DaysUniquePayers":1},"resource":"https://api.magentlab.com/api/calc/impede_vte","extensions":{"bazaar":{"info":{"input":{"body":{"items":[{"esa":false,"imid":false,"bmi_ge_25":false,"doxorubicin":false,"vte_history":false,"dexamethasone":"none","tunneled_line":false,"thromboprophylaxis":"none","asian_pacific_islander":false,"pelvic_hip_femur_fracture":false},{"esa":false,"imid":false,"bmi_ge_25":false,"doxorubicin":false,"vte_history":false,"dexamethasone":"none","tunneled_line":false,"thromboprophylaxis":"none","asian_pacific_islander":false,"pelvic_hip_femur_fracture":false}]},"type":"http","method":"POST"},"output":{"type":"json","example":{"path":"/api/calc/impede_vte","count":2,"items":[{"esa":false,"imid":false,"risk":"low","score":0,"formula":"impede_vte","citation":{"id":"sanfilippo-2019-impede","doi":"10.1002/ajh.25603","pmid":"31374145","title":"Predicting venous thromboembolism in multiple myeloma: development and validation of the IMPEDE VTE score","source":"Am J Hematol. 2019;94(11):1176-1184","authors":"Sanfilippo KM, Luo S, Wang TF, Fiala M, Schoen M, Wildes TM, Mikhael J, Kuderer NM, Calverley DC, Keller J, Thomas T, Carson KR, Gage BF"},"bmi_ge_25":false,"max_score":24,"components":[{"factor":"imid","points":0,"present":false},{"factor":"bmi_ge_25","points":0,"present":false},{"factor":"pelvic_hip_femur_fracture","points":0,"present":false},{"factor":"esa","points":0,"present":false},{"factor":"doxorubicin","points":0,"present":false},{"value":"none","factor":"dexamethasone","points":0,"present":false},{"factor":"asian_pacific_islander","points":0,"present":false},{"factor":"vte_history","points":0,"present":false},{"factor":"tunneled_line","points":0,"present":false},{"value":"none","factor":"thromboprophylaxis","points":0,"present":false}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","doxorubicin":false,"vte_history":false,"dexamethasone":"none","tunneled_line":false,"formula_expression":"IMPEDE VTE (Sanfilippo 2019 Table 3) = imid (4) + bmi_ge_25 (1) + pelvic_hip_femur_fracture (4) + esa (1) + doxorubicin (3) + dexamethasone (none 0, low 2, high 4; high if total monthly dosing >160 mg) + asian_pacific_islander (-3) + vte_history (5) + tunneled_line (2) + thromboprophylaxis (none 0, prophylactic -3, therapeutic -4); unclamped; <=3 low 3.3%, 4-7 intermediate 8.3%, >=8 high 15.2%","thromboprophylaxis":"none","six_month_vte_percent":3.3,"asian_pacific_islander":false,"pelvic_hip_femur_fracture":false},{"esa":false,"imid":false,"risk":"low","score":0,"formula":"impede_vte","citation":{"id":"sanfilippo-2019-impede","doi":"10.1002/ajh.25603","pmid":"31374145","title":"Predicting venous thromboembolism in multiple myeloma: development and validation of the IMPEDE VTE score","source":"Am J Hematol. 2019;94(11):1176-1184","authors":"Sanfilippo KM, Luo S, Wang TF, Fiala M, Schoen M, Wildes TM, Mikhael J, Kuderer NM, Calverley DC, Keller J, Thomas T, Carson KR, Gage BF"},"bmi_ge_25":false,"max_score":24,"components":[{"factor":"imid","points":0,"present":false},{"factor":"bmi_ge_25","points":0,"present":false},{"factor":"pelvic_hip_femur_fracture","points":0,"present":false},{"factor":"esa","points":0,"present":false},{"factor":"doxorubicin","points":0,"present":false},{"value":"none","factor":"dexamethasone","points":0,"present":false},{"factor":"asian_pacific_islander","points":0,"present":false},{"factor":"vte_history","points":0,"present":false},{"factor":"tunneled_line","points":0,"present":false},{"value":"none","factor":"thromboprophylaxis","points":0,"present":false}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","doxorubicin":false,"vte_history":false,"dexamethasone":"none","tunneled_line":false,"formula_expression":"IMPEDE VTE (Sanfilippo 2019 Table 3) = imid (4) + bmi_ge_25 (1) + pelvic_hip_femur_fracture (4) + esa (1) + doxorubicin (3) + dexamethasone (none 0, low 2, high 4; high if total monthly dosing >160 mg) + asian_pacific_islander (-3) + vte_history (5) + tunneled_line (2) + thromboprophylaxis (none 0, prophylactic -3, therapeutic -4); unclamped; <=3 low 3.3%, 4-7 intermediate 8.3%, >=8 high 15.2%","thromboprophylaxis":"none","six_month_vte_percent":3.3,"asian_pacific_islander":false,"pelvic_hip_femur_fracture":false}]}},"iconUrl":"https://api.magentlab.com/favicon.ico"},"schema":{"type":"object","$schema":"https://json-schema.org/draft/2020-12/schema","required":["input"],"properties":{"input":{"type":"object","required":["type","method"],"properties":{"body":{"type":"object","required":["items"],"properties":{"items":{"type":"array","items":{"type":"object","required":["imid","bmi_ge_25","pelvic_hip_femur_fracture","esa","doxorubicin","dexamethasone","asian_pacific_islander","vte_history","tunneled_line","thromboprophylaxis"],"properties":{"esa":{"type":"boolean","description":"Erythropoiesis-stimulating agent as assigned by the caller (Sanfilippo 2019 Table 3). true or false. 1 point if true."},"imid":{"type":"boolean","description":"Immunomodulatory drug (IMiD) as assigned by the caller (Sanfilippo 2019 Table 3). true or false. 4 points if true."},"bmi_ge_25":{"type":"boolean","description":"BMI ≥25 kg/m2 as assigned by the caller (Sanfilippo 2019 Table 3). true or false. magent does not compute BMI from height or weight. 1 point if true."},"doxorubicin":{"type":"boolean","description":"Doxorubicin as assigned by the caller (Sanfilippo 2019 Table 3). true or false. 3 points if true."},"vte_history":{"type":"boolean","description":"History of VTE before multiple myeloma as assigned by the caller (Sanfilippo 2019 Table 3). true or false. 5 points if true."},"dexamethasone":{"enum":["none","low","high"],"type":"string","description":"Dexamethasone as assigned by the caller (Sanfilippo 2019 Table 3). none (not on dexamethasone) scores 0; low (dexamethasone used at total monthly dosing ≤160 mg) scores 2; high (total monthly dosing >160 mg) scores 4. Not the NCCN ≥480 mg definition."},"tunneled_line":{"type":"boolean","description":"Tunneled line / central venous catheter as assigned by the caller (Sanfilippo 2019 Table 3). true or false. 2 points if true."},"thromboprophylaxis":{"enum":["none","prophylactic","therapeutic"],"type":"string","description":"Existing thromboprophylaxis as assigned by the caller (Sanfilippo 2019 Table 3). Mutually exclusive. none scores 0; prophylactic (prophylactic LMWH or aspirin) scores −3; therapeutic (therapeutic LMWH or warfarin) scores −4."},"asian_pacific_islander":{"type":"boolean","description":"Caller-assigned ethnicity/race Asian/Pacific Islander as used in Sanfilippo 2019. true or false. magent does not assign race or ethnicity. −3 if true."},"pelvic_hip_femur_fracture":{"type":"boolean","description":"Pelvic, hip, or femur fracture as assigned by the caller (Sanfilippo 2019 Table 3). true or false. 4 points if true."}}},"maxItems":25,"minItems":1}},"additionalProperties":false},"type":{"type":"string","const":"http"},"method":{"type":"string","const":"POST"},"headers":{"type":"object","additionalProperties":{"type":"string"}}},"additionalProperties":false},"output":{"type":"object","required":["type"],"properties":{"type":{"type":"string"},"example":{"type":"object"}}}}}}},"description":"Sanfilippo 2019 IMPEDE VTE for multiple myeloma: IMiD 4, BMI>=25 1, pelvic/hip/femur fracture 4, ESA 1, doxorubicin 3, dexamethasone none/low/high 0/2/4 (high if monthly >160 mg), Asian/Pacific Islander -3 (caller-assigned), VTE history 5, tunneled line 2, thromboprophylaxis none/prophylactic/therapeutic 0/-3/-4. Unclamped. <=3 low 3.3%, 4-7 intermediate 8.3%, >=8 high 15.2%. Not a prophylaxis order. Not SAVED or Khorana.","lastUpdated":"2026-09-28T14:27:52.515Z","serviceName":"magent","x402Version":2}]}}